Neos Therapeutics Inc. (NEOS)

5.7 -0.1 (-1.724%)

IEX Real-Time Price

August 17, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 5.8

Price Open 5.75

Volume: 272,634

Avg Volume: 212,892

Market Cap: 169.14M

P/E Ratio -2.73

52 Wk Range 5.3-13.15



NEOS Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
27.13M
1.89M
8.83
6.97%

2018-07-13
27.13M
1.97M
7.47
7.26%

2018-06-29
27.13M
2.12M
4.58
7.83%

2018-06-15
27.13M
1.86M
4.08
6.87%




NEOS Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-09
Q1 2018
BTO
-0.51 (2)
-0.50
0.01

2018-05-08
Q1 2018
N/A
-0.50 (2)
0.00
0.00

2018-03-15
Q4 2017
BTO
-0.61 (2)
-0.49
0.12

2018-03-13
Q4 2017
N/A
-0.60 (2)
-0.49
0.12

News

Neos Therapeutics: Growth Story Remains Intact (2018-08-10 11:34 SeekingAlpha)

"One man to live in pleasure and wealth, whiles all other weep and smart for it, that is the part not of a king, but of a jailor." - Thomas More In today's analysis, we revisit Neos Therapeutics ( NEOS ) after the company recently posted second quarter earnings. Company Overview Ne…

 


Statistics

Shares Outstanding: 29.67M

Top 15 Institution Percent: 54.10

Price To Sales: 4.71

Price To Book: 30.50

Revenue: 6.70M

Gross Profit: 4.27M

Cash: 66.49M

Debt: 65.92M

Return On Assets: -59.33

Return On Equity: -1797.13

Profit Margin: N/A

Price History

Beta: -0.38

50-day Moving Avg: 6.17

200-day Moving Avg: 8.41

YTD Change: -45.19

5-day Change: -6.56

1-month Change: -10.24

3-month Change: -24.50

6-month Change: -36.31

1-year Change: -14.93

Revenue Per Share: 0.00

Revenue Per Employee: 48514.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Neos Therapeutics Inc.

Exchange: NASDAQ Global Market

Industry: Drug Manufacturers

Sector: Healthcare

Website: http://www.neostx.com

Neos Therapeutics Inc is a pharmaceutical company, engaged in the development, manufacture, and commercialization of products for the treatment of attention deficit hyperactivity disorder using its drug delivery technologies.